Logo image of CROX

CROCS INC (CROX) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CROX - US2270461096 - Common Stock

86.63 USD
+1.65 (+1.94%)
Last: 12/1/2025, 8:00:00 PM
86.63 USD
0 (0%)
After Hours: 12/1/2025, 8:00:00 PM
Fundamental Rating

7

CROX gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 46 industry peers in the Textiles, Apparel & Luxury Goods industry. CROX gets an excellent profitability rating and is at the same time showing great financial health properties. A decent growth rate in combination with a cheap valuation! Better keep an eye on CROX. With these ratings, CROX could be worth investigating further for value and quality investing!.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

CROX had positive earnings in the past year.
In the past year CROX had a positive cash flow from operations.
In the past 5 years CROX has always been profitable.
In the past 5 years CROX always reported a positive cash flow from operatings.
CROX Yearly Net Income VS EBIT VS OCF VS FCFCROX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B -1.5B

1.2 Ratios

CROX's Return On Assets of 4.25% is fine compared to the rest of the industry. CROX outperforms 63.04% of its industry peers.
With a decent Return On Equity value of 13.39%, CROX is doing good in the industry, outperforming 71.74% of the companies in the same industry.
With an excellent Return On Invested Capital value of 23.59%, CROX belongs to the best of the industry, outperforming 89.13% of the companies in the same industry.
CROX had an Average Return On Invested Capital over the past 3 years of 22.59%. This is significantly above the industry average of 11.99%.
The last Return On Invested Capital (23.59%) for CROX is above the 3 year average (22.59%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.25%
ROE 13.39%
ROIC 23.59%
ROA(3y)16.27%
ROA(5y)24.75%
ROE(3y)57.44%
ROE(5y)1085.36%
ROIC(3y)22.59%
ROIC(5y)29.82%
CROX Yearly ROA, ROE, ROICCROX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K 4K 5K

1.3 Margins

The Profit Margin of CROX (4.48%) is better than 63.04% of its industry peers.
In the last couple of years the Profit Margin of CROX has grown nicely.
CROX has a better Operating Margin (23.11%) than 95.65% of its industry peers.
In the last couple of years the Operating Margin of CROX has grown nicely.
CROX has a Gross Margin of 59.08%. This is in the better half of the industry: CROX outperforms 73.91% of its industry peers.
CROX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 23.11%
PM (TTM) 4.48%
GM 59.08%
OM growth 3Y-5.12%
OM growth 5Y19.52%
PM growth 3Y-9.62%
PM growth 5Y18.99%
GM growth 3Y-1.45%
GM growth 5Y3.22%
CROX Yearly Profit, Operating, Gross MarginsCROX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

7

2. Health

2.1 Basic Checks

CROX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for CROX has been reduced compared to 1 year ago.
CROX has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, CROX has an improved debt to assets ratio.
CROX Yearly Shares OutstandingCROX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CROX Yearly Total Debt VS Total AssetsCROX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

CROX has an Altman-Z score of 3.77. This indicates that CROX is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of CROX (3.77) is better than 73.91% of its industry peers.
The Debt to FCF ratio of CROX is 1.84, which is an excellent value as it means it would take CROX, only 1.84 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CROX (1.84) is better than 84.78% of its industry peers.
CROX has a Debt/Equity ratio of 0.97. This is a neutral value indicating CROX is somewhat dependend on debt financing.
CROX's Debt to Equity ratio of 0.97 is on the low side compared to the rest of the industry. CROX is outperformed by 73.91% of its industry peers.
Although CROX does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 1.84
Altman-Z 3.77
ROIC/WACC2.09
WACC11.31%
CROX Yearly LT Debt VS Equity VS FCFCROX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

2.3 Liquidity

CROX has a Current Ratio of 1.40. This is a normal value and indicates that CROX is financially healthy and should not expect problems in meeting its short term obligations.
CROX's Current ratio of 1.40 is on the low side compared to the rest of the industry. CROX is outperformed by 76.09% of its industry peers.
CROX has a Quick Ratio of 1.40. This is a bad value and indicates that CROX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.83, CROX is not doing good in the industry: 65.22% of the companies in the same industry are doing better.
The current and quick ratio evaluation for CROX is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.4
Quick Ratio 0.83
CROX Yearly Current Assets VS Current LiabilitesCROX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

The earnings per share for CROX have decreased by -4.09% in the last year.
The Earnings Per Share has been growing by 51.64% on average over the past years. This is a very strong growth
CROX shows a small growth in Revenue. In the last year, the Revenue has grown by 0.01%.
CROX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 27.23% yearly.
EPS 1Y (TTM)-4.09%
EPS 3Y16.39%
EPS 5Y51.64%
EPS Q2Q%-18.89%
Revenue 1Y (TTM)0.01%
Revenue growth 3Y21.04%
Revenue growth 5Y27.23%
Sales Q2Q%-6.2%

3.2 Future

The Earnings Per Share is expected to grow by 2.84% on average over the next years.
The Revenue is expected to grow by 2.29% on average over the next years.
EPS Next Y-8.89%
EPS Next 2Y-3.86%
EPS Next 3Y-2.79%
EPS Next 5Y2.84%
Revenue Next Year-1.88%
Revenue Next 2Y-1.1%
Revenue Next 3Y-1.32%
Revenue Next 5Y2.29%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CROX Yearly Revenue VS EstimatesCROX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
CROX Yearly EPS VS EstimatesCROX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 5 10 15

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 6.84 indicates a rather cheap valuation of CROX.
Based on the Price/Earnings ratio, CROX is valued cheaper than 93.48% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.11. CROX is valued rather cheaply when compared to this.
CROX is valuated cheaply with a Price/Forward Earnings ratio of 7.13.
Based on the Price/Forward Earnings ratio, CROX is valued cheaply inside the industry as 95.65% of the companies are valued more expensively.
CROX is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.21, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 6.84
Fwd PE 7.13
CROX Price Earnings VS Forward Price EarningsCROX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CROX is valued cheaply inside the industry as 86.96% of the companies are valued more expensively.
91.30% of the companies in the same industry are more expensive than CROX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 6.28
EV/EBITDA 5.57
CROX Per share dataCROX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The excellent profitability rating of CROX may justify a higher PE ratio.
A cheap valuation may be justified as CROX's earnings are expected to decrease with -2.79% in the coming years.
PEG (NY)N/A
PEG (5Y)0.13
EPS Next 2Y-3.86%
EPS Next 3Y-2.79%

0

5. Dividend

5.1 Amount

CROX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CROCS INC

NASDAQ:CROX (12/1/2025, 8:00:00 PM)

After market: 86.63 0 (0%)

86.63

+1.65 (+1.94%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)10-30 2025-10-30/bmo
Earnings (Next)02-11 2026-02-11/amc
Inst Owners103.9%
Inst Owner Change-8.08%
Ins Owners2.6%
Ins Owner Change2.4%
Market Cap4.50B
Revenue(TTM)4.07B
Net Income(TTM)182.55M
Analysts73.64
Price Target93.39 (7.8%)
Short Float %12.89%
Short Ratio3.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.3%
Min EPS beat(2)3.5%
Max EPS beat(2)21.1%
EPS beat(4)4
Avg EPS beat(4)13.09%
Min EPS beat(4)3.5%
Max EPS beat(4)21.1%
EPS beat(8)8
Avg EPS beat(8)14.51%
EPS beat(12)12
Avg EPS beat(12)14.26%
EPS beat(16)16
Avg EPS beat(16)14.77%
Revenue beat(2)1
Avg Revenue beat(2)0.15%
Min Revenue beat(2)-1.17%
Max Revenue beat(2)1.48%
Revenue beat(4)3
Avg Revenue beat(4)0.6%
Min Revenue beat(4)-1.17%
Max Revenue beat(4)1.48%
Revenue beat(8)4
Avg Revenue beat(8)0.38%
Revenue beat(12)6
Avg Revenue beat(12)0.28%
Revenue beat(16)9
Avg Revenue beat(16)0.56%
PT rev (1m)4.2%
PT rev (3m)-3.29%
EPS NQ rev (1m)8.05%
EPS NQ rev (3m)-1.39%
EPS NY rev (1m)3.04%
EPS NY rev (3m)-0.66%
Revenue NQ rev (1m)-0.75%
Revenue NQ rev (3m)-2.8%
Revenue NY rev (1m)0.54%
Revenue NY rev (3m)-0.29%
Valuation
Industry RankSector Rank
PE 6.84
Fwd PE 7.13
P/S 1.1
P/FCF 6.28
P/OCF 5.77
P/B 3.3
P/tB N/A
EV/EBITDA 5.57
EPS(TTM)12.67
EY14.63%
EPS(NY)12.15
Fwd EY14.03%
FCF(TTM)13.79
FCFY15.92%
OCF(TTM)15.02
OCFY17.34%
SpS78.44
BVpS26.25
TBVpS-7.17
PEG (NY)N/A
PEG (5Y)0.13
Graham Number86.51
Profitability
Industry RankSector Rank
ROA 4.25%
ROE 13.39%
ROCE 26.08%
ROIC 23.59%
ROICexc 24.64%
ROICexgc 49.52%
OM 23.11%
PM (TTM) 4.48%
GM 59.08%
FCFM 17.59%
ROA(3y)16.27%
ROA(5y)24.75%
ROE(3y)57.44%
ROE(5y)1085.36%
ROIC(3y)22.59%
ROIC(5y)29.82%
ROICexc(3y)23.62%
ROICexc(5y)33.95%
ROICexgc(3y)69.79%
ROICexgc(5y)62.49%
ROCE(3y)24.97%
ROCE(5y)32.97%
ROICexgc growth 3Y-0.46%
ROICexgc growth 5Y13.47%
ROICexc growth 3Y-28.38%
ROICexc growth 5Y-4.85%
OM growth 3Y-5.12%
OM growth 5Y19.52%
PM growth 3Y-9.62%
PM growth 5Y18.99%
GM growth 3Y-1.45%
GM growth 5Y3.22%
F-Score6
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 1.84
Debt/EBITDA 1.3
Cap/Depr 83.38%
Cap/Sales 1.56%
Interest Coverage 11.87
Cash Conversion 76.65%
Profit Quality 392.36%
Current Ratio 1.4
Quick Ratio 0.83
Altman-Z 3.77
F-Score6
WACC11.31%
ROIC/WACC2.09
Cap/Depr(3y)1933.24%
Cap/Depr(5y)1225.32%
Cap/Sales(3y)21.71%
Cap/Sales(5y)14.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.09%
EPS 3Y16.39%
EPS 5Y51.64%
EPS Q2Q%-18.89%
EPS Next Y-8.89%
EPS Next 2Y-3.86%
EPS Next 3Y-2.79%
EPS Next 5Y2.84%
Revenue 1Y (TTM)0.01%
Revenue growth 3Y21.04%
Revenue growth 5Y27.23%
Sales Q2Q%-6.2%
Revenue Next Year-1.88%
Revenue Next 2Y-1.1%
Revenue Next 3Y-1.32%
Revenue Next 5Y2.29%
EBIT growth 1Y-11.62%
EBIT growth 3Y14.85%
EBIT growth 5Y52.06%
EBIT Next Year-9.8%
EBIT Next 3Y-6.47%
EBIT Next 5Y3.43%
FCF growth 1Y-14.34%
FCF growth 3Y21.77%
FCF growth 5Y76.83%
OCF growth 1Y-16.78%
OCF growth 3Y20.5%
OCF growth 5Y61.62%

CROCS INC / CROX FAQ

What is the ChartMill fundamental rating of CROCS INC (CROX) stock?

ChartMill assigns a fundamental rating of 7 / 10 to CROX.


What is the valuation status for CROX stock?

ChartMill assigns a valuation rating of 8 / 10 to CROCS INC (CROX). This can be considered as Undervalued.


What is the profitability of CROX stock?

CROCS INC (CROX) has a profitability rating of 9 / 10.


What are the PE and PB ratios of CROCS INC (CROX) stock?

The Price/Earnings (PE) ratio for CROCS INC (CROX) is 6.84 and the Price/Book (PB) ratio is 3.3.


Can you provide the financial health for CROX stock?

The financial health rating of CROCS INC (CROX) is 7 / 10.